Date: 2012-10-23
Type of information: Production agreement
Compound: antibody drug conjugates (ADCs)
Company: Fujifilm Diosynth Biotechnologies UK (UK) Piramal (india)
Therapeutic area:
Type agreement: manufacturing
production
Action mechanism:
Disease:
Details: The biologics Contract Development and Manufacturing Organization (CDMO) Fujifilm Diosynth Biotechnologies UK has announced it has entered into a strategic alliance with Piramal Healthcare UK Ltd, whereby the two parties will offer the seamless contract development and manufacture of antibody drug conjugates (ADCs). The deal will allow customers to benefit from the experience and assets of both organisations, while simplifying the supply chain and vendor management relationships, leading to shorter time to clinic. For Fujifilm Diosynth Biotechnologies, this is part of an ongoing programme to expand its offering in mammalian-based biopharmaceuticals. The company recently announced an expansion of its cGMP manufacturing facilities at both its RTP, USA and Billingham, UK sites.
Financial terms:
Latest news:
